APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Naloxone

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Naloxone Market Outlook and Growth Opportunities 2026

Report ID 174015560420 December 2025191 pages

Choose your research edition.

Industry ResearchNaloxone Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Naloxone Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Naloxone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naloxone Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Naloxone Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Naloxone market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Naloxone market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Naloxone market include ADAPT Pharma, Amneal Pharmaceuticals, Amphastar Pharmaceuticals, Kaleo, West Ward Pharmaceuticals, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Naloxone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Naloxone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Naloxone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Naloxone market size, projected growth trends, production technologies, key applications, and end-use industries.

Naloxone Segment by Company

ADAPT Pharma

Amneal Pharmaceuticals

Amphastar Pharmaceuticals

Kaleo

West Ward Pharmaceuticals

Pfizer

Mylan

Sandoz

Naloxone Segment by Type

Spray Forms

Injectable Forms

Naloxone Segment by Application

Hospital Pharmacies

Drug Store

Online

Naloxone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Naloxone status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Naloxone market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Naloxone significant trends, drivers, influence factors in global and regions.

6. To analyze Naloxone competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naloxone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naloxone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naloxone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Naloxone market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Naloxone industry.

Chapter 3: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Naloxone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Naloxone in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Naloxone Industry Trends Table 2. Naloxone Industry Drivers Table 3. Naloxone Industry Opportunities and Challenges Table 4. Naloxone Industry Restraints Table 5. Global Naloxone Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Naloxone Revenue Share by Company (2021-2026) Table 7. Global Naloxone Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Naloxone Sales Volume Share by Company (2021-2026) Table 9. Global Naloxone Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Naloxone Company Ranking, (2024-2026) & (USD Million) Table 11. Global Naloxone Key Company Manufacturing Base & Headquarters Table 12. Global Naloxone Company, Product Type & Application Table 13. Global Naloxone Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Naloxone by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Spray Forms Table 18. Significant Companies of Injectable Forms Table 19. Global Naloxone Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Naloxone Sales Volume by Type (2021-2026) & (W Units) Table 21. Global Naloxone Sales Volume by Type (2027-2032) & (W Units) Table 22. Global Naloxone Sales Volume Share by Type (2021-2026) Table 23. Global Naloxone Sales Volume Share by Type (2027-2032) Table 24. Global Naloxone Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Naloxone Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Naloxone Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Naloxone Sales Value Share by Type (2021-2026) Table 28. Global Naloxone Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Drug Store Table 31. Significant Companies of Online Table 32. Global Naloxone Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Naloxone Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Naloxone Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Naloxone Sales Volume Share by Application (2021-2026) Table 36. Global Naloxone Sales Volume Share by Application (2027-2032) Table 37. Global Naloxone Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Naloxone Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Naloxone Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Naloxone Sales Value Share by Application (2021-2026) Table 41. Global Naloxone Sales Value Share by Application (2027-2032) Table 42. Global Naloxone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Naloxone Sales by Region (2021-2026) & (W Units) Table 44. Global Naloxone Sales Market Share by Region (2021-2026) Table 45. Global Naloxone Sales by Region (2027-2032) & (W Units) Table 46. Global Naloxone Sales Market Share by Region (2027-2032) Table 47. Global Naloxone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Naloxone Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Naloxone Sales Value Share by Region (2021-2026) Table 50. Global Naloxone Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Naloxone Sales Value Share by Region (2027-2032) Table 52. Global Naloxone Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Naloxone Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Naloxone Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Naloxone Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Naloxone Sales by Country (2021-2026) & (W Units) Table 57. Global Naloxone Sales Market Share by Country (2021-2026) Table 58. Global Naloxone Sales by Country (2027-2032) & (W Units) Table 59. Global Naloxone Sales Market Share by Country (2027-2032) Table 60. Global Naloxone Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Naloxone Sales Value Market Share by Country (2021-2026) Table 62. Global Naloxone Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Naloxone Sales Value Market Share by Country (2027-2032) Table 64. ADAPT Pharma Company Information Table 65. ADAPT Pharma Business Overview Table 66. ADAPT Pharma Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. ADAPT Pharma Naloxone Product Portfolio Table 68. ADAPT Pharma Recent Development Table 69. Amneal Pharmaceuticals Company Information Table 70. Amneal Pharmaceuticals Business Overview Table 71. Amneal Pharmaceuticals Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Amneal Pharmaceuticals Naloxone Product Portfolio Table 73. Amneal Pharmaceuticals Recent Development Table 74. Amphastar Pharmaceuticals Company Information Table 75. Amphastar Pharmaceuticals Business Overview Table 76. Amphastar Pharmaceuticals Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Amphastar Pharmaceuticals Naloxone Product Portfolio Table 78. Amphastar Pharmaceuticals Recent Development Table 79. Kaleo Company Information Table 80. Kaleo Business Overview Table 81. Kaleo Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Kaleo Naloxone Product Portfolio Table 83. Kaleo Recent Development Table 84. West Ward Pharmaceuticals Company Information Table 85. West Ward Pharmaceuticals Business Overview Table 86. West Ward Pharmaceuticals Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. West Ward Pharmaceuticals Naloxone Product Portfolio Table 88. West Ward Pharmaceuticals Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pfizer Naloxone Product Portfolio Table 93. Pfizer Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mylan Naloxone Product Portfolio Table 98. Mylan Recent Development Table 99. Sandoz Company Information Table 100. Sandoz Business Overview Table 101. Sandoz Naloxone Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Sandoz Naloxone Product Portfolio Table 103. Sandoz Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Naloxone Distributors List Table 107. Naloxone Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Naloxone Product Image Figure 2. Global Naloxone Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naloxone Sales Value (2021-2032) & (US$ Million) Figure 4. Global Naloxone Sales (2021-2032) & (W Units) Figure 5. Global Naloxone Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Naloxone Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Spray Forms Image Figure 10. Injectable Forms Image Figure 11. Global Naloxone Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Naloxone Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Naloxone Sales Volume Share by Type (2021-2032) Figure 14. Global Naloxone Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Naloxone Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Naloxone Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Drug Store Image Figure 19. Online Image Figure 20. Global Naloxone Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Naloxone Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Naloxone Sales Volume Share by Application (2021-2032) Figure 23. Global Naloxone Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Naloxone Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Naloxone Sales Value Share by Application (2021-2032) Figure 26. Global Naloxone Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Naloxone Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Naloxone Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Naloxone Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Naloxone Sales Value (2021-2032) & (US$ Million) Figure 31. North America Naloxone Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Naloxone Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Naloxone Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Naloxone Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Naloxone Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Naloxone Sales Value (2021-2032) & (US$ Million) Figure 37. South America Naloxone Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Naloxone Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Naloxone Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Naloxone Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Naloxone Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Naloxone Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Naloxone Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Naloxone Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Spray Forms
  • Injectable Forms
Applications
  • Hospital Pharmacies
  • Drug Store
  • Online
Companies covered
  • ADAPT Pharma
  • Amneal Pharmaceuticals
  • Amphastar Pharmaceuticals
  • Kaleo
  • West Ward Pharmaceuticals
  • Pfizer
  • Mylan
  • Sandoz

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Naloxone Sales Value (2021-2032)
  4. 1.2.2 Global Naloxone Sales Volume (2021-2032)
  5. 1.2.3 Global Naloxone Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Naloxone Market Dynamics
  1. 2.1 Naloxone Industry Trends
  2. 2.2 Naloxone Industry Drivers
  3. 2.3 Naloxone Industry Opportunities and Challenges
  4. 2.4 Naloxone Industry Restraints
3 Naloxone Market by Company
  1. 3.1 Global Naloxone Company Revenue Ranking in 2025
  2. 3.2 Global Naloxone Revenue by Company (2021-2026)
  3. 3.3 Global Naloxone Sales Volume by Company (2021-2026)
  4. 3.4 Global Naloxone Average Price by Company (2021-2026)
  5. 3.5 Global Naloxone Company Ranking (2024-2026)
  6. 3.6 Global Naloxone Company Manufacturing Base and Headquarters
  7. 3.7 Global Naloxone Company Product Type and Application
  8. 3.8 Global Naloxone Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Naloxone Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Naloxone Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Naloxone Market by Type
  1. 4.1 Naloxone Type Introduction
  2. 4.1.1 Spray Forms
  3. 4.1.2 Injectable Forms
  4. 4.2 Global Naloxone Sales Volume by Type
  5. 4.2.1 Global Naloxone Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Naloxone Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Naloxone Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Naloxone Sales Value by Type
  9. 4.3.1 Global Naloxone Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Naloxone Sales Value by Type (2021-2032)
  11. 4.3.3 Global Naloxone Sales Value Share by Type (2021-2032)
5 Naloxone Market by Application
  1. 5.1 Naloxone Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Store
  4. 5.1.3 Online
  5. 5.2 Global Naloxone Sales Volume by Application
  6. 5.2.1 Global Naloxone Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Naloxone Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Naloxone Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Naloxone Sales Value by Application
  10. 5.3.1 Global Naloxone Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Naloxone Sales Value by Application (2021-2032)
  12. 5.3.3 Global Naloxone Sales Value Share by Application (2021-2032)
6 Naloxone Regional Sales and Value Analysis
  1. 6.1 Global Naloxone Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Naloxone Sales by Region (2021-2032)
  3. 6.2.1 Global Naloxone Sales by Region: 2021-2026
  4. 6.2.2 Global Naloxone Sales by Region (2027-2032)
  5. 6.3 Global Naloxone Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Naloxone Sales Value by Region (2021-2032)
  7. 6.4.1 Global Naloxone Sales Value by Region: 2021-2026
  8. 6.4.2 Global Naloxone Sales Value by Region (2027-2032)
  9. 6.5 Global Naloxone Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Naloxone Sales Value (2021-2032)
  12. 6.6.2 North America Naloxone Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Naloxone Sales Value (2021-2032)
  15. 6.7.2 Europe Naloxone Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Naloxone Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Naloxone Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Naloxone Sales Value (2021-2032)
  21. 6.9.2 South America Naloxone Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Naloxone Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Naloxone Sales Value Share by Country, 2025 VS 2032
7 Naloxone Country-level Sales and Value Analysis
  1. 7.1 Global Naloxone Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Naloxone Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Naloxone Sales by Country (2021-2032)
  4. 7.3.1 Global Naloxone Sales by Country (2021-2026)
  5. 7.3.2 Global Naloxone Sales by Country (2027-2032)
  6. 7.4 Global Naloxone Sales Value by Country (2021-2032)
  7. 7.4.1 Global Naloxone Sales Value by Country (2021-2026)
  8. 7.4.2 Global Naloxone Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Naloxone Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Naloxone Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Naloxone Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Naloxone Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Naloxone Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Naloxone Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Naloxone Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Naloxone Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Naloxone Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Naloxone Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Naloxone Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Naloxone Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Naloxone Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Naloxone Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Naloxone Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Naloxone Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Naloxone Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Naloxone Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Naloxone Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Naloxone Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Naloxone Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Naloxone Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Naloxone Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Naloxone Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Naloxone Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Naloxone Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Naloxone Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Naloxone Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Naloxone Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Naloxone Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Naloxone Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Naloxone Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Naloxone Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Naloxone Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Naloxone Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Naloxone Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Naloxone Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Naloxone Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Naloxone Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Naloxone Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Naloxone Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Naloxone Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Naloxone Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Naloxone Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Naloxone Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Naloxone Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Naloxone Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Naloxone Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Naloxone Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Naloxone Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Naloxone Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Naloxone Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Naloxone Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Naloxone Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Naloxone Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Naloxone Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Naloxone Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Naloxone Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Naloxone Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Naloxone Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Naloxone Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Naloxone Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Naloxone Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Naloxone Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Naloxone Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Naloxone Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Naloxone Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Naloxone Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Naloxone Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Naloxone Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Naloxone Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Naloxone Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Naloxone Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Naloxone Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Naloxone Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Naloxone Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Naloxone Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Naloxone Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Naloxone Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Naloxone Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Naloxone Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Naloxone Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Naloxone Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Naloxone Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 ADAPT Pharma
  2. 8.1.1 ADAPT Pharma Company Information
  3. 8.1.2 ADAPT Pharma Business Overview
  4. 8.1.3 ADAPT Pharma Naloxone Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 ADAPT Pharma Naloxone Product Portfolio
  6. 8.1.5 ADAPT Pharma Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Naloxone Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Naloxone Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Amphastar Pharmaceuticals
  14. 8.3.1 Amphastar Pharmaceuticals Company Information
  15. 8.3.2 Amphastar Pharmaceuticals Business Overview
  16. 8.3.3 Amphastar Pharmaceuticals Naloxone Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amphastar Pharmaceuticals Naloxone Product Portfolio
  18. 8.3.5 Amphastar Pharmaceuticals Recent Developments
  19. 8.4 Kaleo
  20. 8.4.1 Kaleo Company Information
  21. 8.4.2 Kaleo Business Overview
  22. 8.4.3 Kaleo Naloxone Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kaleo Naloxone Product Portfolio
  24. 8.4.5 Kaleo Recent Developments
  25. 8.5 West Ward Pharmaceuticals
  26. 8.5.1 West Ward Pharmaceuticals Company Information
  27. 8.5.2 West Ward Pharmaceuticals Business Overview
  28. 8.5.3 West Ward Pharmaceuticals Naloxone Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 West Ward Pharmaceuticals Naloxone Product Portfolio
  30. 8.5.5 West Ward Pharmaceuticals Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Naloxone Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Naloxone Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Naloxone Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Naloxone Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Sandoz
  44. 8.8.1 Sandoz Company Information
  45. 8.8.2 Sandoz Business Overview
  46. 8.8.3 Sandoz Naloxone Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sandoz Naloxone Product Portfolio
  48. 8.8.5 Sandoz Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Naloxone Value Chain Analysis
  2. 9.1.1 Naloxone Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Naloxone Sales Mode & Process
  6. 9.2 Naloxone Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Naloxone Distributors
  9. 9.2.3 Naloxone Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst